Variant report
Variant | rs55700391 |
---|---|
Chromosome Location | chr21:46102209-46102210 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | RCOR1 | chr21:46102169-46102727 | K562 | blood: | n/a | n/a |
2 | FOS | chr21:46102140-46102369 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | STAT3 | chr21:46102155-46102355 | MCF10A-Er-Src | breast: | n/a | chr21:46102187-46102196 chr21:46102184-46102198 chr21:46102186-46102195 |
4 | TAL1 | chr21:46102157-46102429 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46096720..46098322-chr21:46101281..46103143,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRTAP12-1 | TF binding region |
IMMTP1 | TF binding region |
ENSG00000229880 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs12329668 | 1.00[ASN][1000 genomes] |
rs17211921 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17213734 | 0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17213972 | 0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17284014 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17284056 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17284167 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17285096 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17285396 | 0.84[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17285466 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17285795 | 0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17286075 | 0.94[EUR][1000 genomes] |
rs2329891 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2329896 | 1.00[ASN][1000 genomes] |
rs2838628 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs28658387 | 0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs36091286 | 1.00[ASN][1000 genomes] |
rs4401291 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55781313 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55805293 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55830574 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55877354 | 0.80[EUR][1000 genomes] |
rs55881656 | 0.85[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes] |
rs55929251 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs55962178 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56008135 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56019874 | 1.00[AFR][1000 genomes];0.89[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56135164 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56138130 | 1.00[ASN][1000 genomes] |
rs56277017 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs56310126 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs59742230 | 1.00[ASN][1000 genomes] |
rs60533424 | 0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73233077 | 1.00[ASN][1000 genomes] |
rs73233084 | 1.00[ASN][1000 genomes] |
rs73233088 | 1.00[ASN][1000 genomes] |
rs73233095 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73233102 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234804 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234823 | 0.80[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234825 | 1.00[ASN][1000 genomes] |
rs73234826 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234827 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234828 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234830 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234831 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234832 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234833 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234834 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234835 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234839 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234841 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234848 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234850 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234853 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73234870 | 0.89[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs875125 | 1.00[ASN][1000 genomes] |
rs9978068 | 1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv916258 | chr21:45995986-46624705 | Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 102 gene(s) | inside rSNPs | diseases |
2 | nsv913956 | chr21:46096964-46279505 | Enhancers Bivalent Enhancer Active TSS Weak transcription Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
3 | nsv1062245 | chr21:46096964-46332587 | Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 51 gene(s) | inside rSNPs | diseases |
4 | nsv544478 | chr21:46096964-46332587 | Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 51 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46094200-46106800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr21:46098200-46104600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr21:46101000-46122200 | Weak transcription | Right Atrium | heart |
4 | chr21:46102000-46102800 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
5 | chr21:46102200-46102400 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
6 | chr21:46102200-46103000 | Bivalent Enhancer | K562 | blood |